Epstein-Barr Virus (EBV) Is Mostly Latent and Clonal in Angioimmunoblastic T Cell Lymphoma (AITL)

被引:12
|
作者
Bahri, Racha [1 ,2 ,3 ]
Boyer, Francois [2 ,3 ]
Halabi, Mohamad Adnan [1 ]
Chaunavel, Alain [4 ]
Feuillard, Jean [2 ,3 ,5 ]
Jaccard, Arnaud [2 ,3 ,6 ]
Ranger-Rogez, Sylvie [1 ,2 ,3 ,7 ]
机构
[1] Fac Pharm, Microbiol Dept, F-87025 Limoges, France
[2] CNRS Ctr Natl Rech Sci 7276, Unite Mixte Rech, F-87025 Limoges, France
[3] INSERM, U1262, F-87025 Limoges, France
[4] Univ Hosp Dupuytren, Pathol Dept, F-87000 Limoges, France
[5] Univ Hosp Dupuytren, Biol Hematol Dept, F-87000 Limoges, France
[6] Univ Hosp Dupuytren, Clin Hematol Dept, F-87042 Limoges, France
[7] Univ Hosp Dupuytren, Virol Dept, F-87000 Limoges, France
关键词
angioimmunoblastic T cell lymphoma; AITL; Epstein-Barr virus; EBV; clonal; latent; NGS; B-CELL; SEQUENCE; GENOME; TUMOR; DIVERSITY; ALIGNMENT; LYMPHADENOPATHY; IMMUNOGLOBULIN; PATTERNS; TISSUE;
D O I
10.3390/cancers14122899
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Angioimmunoblastic T cell lymphoma (AITL) is the most common peripheral T cell lymphoma encountered in Europe. It is a non-Hodgkin's lymphoma with a poor prognosis. The Epstein-Barr virus (EBV) virus is detected in more than 90% of biopsies, especially in large B lymphocytes. To date, the role of EBV in this pathology is still debated. The aim of our study was to analyze whole viral genomes in AITL compared to other EBV-associated lymphomas. We observed that two viral strains were mainly found in AITL, one of which appeared to be associated with poor post-diagnosis survival. Furthermore, the virus was found to be clonal and latent in all cases of AITL; for one biopsy, the virus was both latent and most likely replicative, depending on the cells. On the whole, these results support a role for EBV in AITL. The Epstein-Barr virus (EBV) is associated with angioimmunoblastic T cell lymphoma (AITL), a peripheral T lymphoma of poor prognosis in at least 90% of cases. The role of EBV in this pathology is unknown. Using next-generation sequencing, we sequenced the entire EBV genome in biopsies from 18 patients with AITL, 16 patients with another EBV-associated lymphoma, and 2 controls. We chose an EBV target capture method, given the high specificity of this technique, followed by a second capture to increase sensitivity. We identified two main viral strains in AITL, one of them associated with the mutations BNRF1 S542N and BZLF1 A206S and with mutations in the EBNA-3 and LMP-2 genes. This strain was characterized in patients with short post-diagnosis survival. The main mutations found during AITL on the most mutated latency or tegument genes were identified and discussed. We showed that the virus was clonal in all the AITL samples, suggesting that it may be involved in this pathology. Additionally, EBV was latent in all the AITL samples; for one sample only, the virus was found to be latent and probably replicative, depending on the cells. These various elements support the role of EBV in AITL.
引用
收藏
页数:26
相关论文
共 50 条
  • [21] Epstein-Barr virus (EBV)-associated aggressive peripheral T-cell lymphoma showing folliculotropism
    Choi, HJ
    Chang, SE
    Koh, JK
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2006, 45 (05) : 631 - 633
  • [22] Secondary Epstein-Barr virus associated lymphoproliferative disorder developing in a patient with angioimmunoblastic T cell lymphoma on vorinostat
    Smeltzer, Jacob P.
    Viswanatha, David S.
    Habermann, Thomas M.
    Patnaik, Mrinal M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (09) : 927 - 928
  • [23] Angioimmunoblastic T-Cell lymphoma, diffuse large B-Cell lymphoma, and Hodgkin lymphoma associated with Epstein-Barr virus infection
    Talwalkar, SS
    Shaheen, SP
    Yem, L
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 124 (04) : 643 - 644
  • [24] Bortezomib is a novel inducer of latent Epstein Barr virus (EBV) in EBV plus lymphoma cell lines
    Kaluza, Vesna
    Brown, Helen J.
    Calimlim, Jeffrey
    Sun, Ren
    De Vos, Sven
    CANCER RESEARCH, 2006, 66 (08)
  • [25] Angioimmunoblastic T-cell lymphoma (angioimmunoblastic lymphadenopathy with dysproteinemia [AILD]-type T-cell lymphoma) followed by Hodgkin's disease associated with Epstein-Barr virus
    Nakamura, S
    Sasajima, Y
    Koshikawa, T
    Kitoh, K
    Koike, K
    Motoori, T
    Ueda, R
    Mori, S
    Suchi, T
    PATHOLOGY INTERNATIONAL, 1995, 45 (12) : 958 - 964
  • [26] Epstein-Barr virus (EBV) and lymphomagenesis
    Cesarman, E
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2002, 7 : E58 - E65
  • [27] The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment
    Gru, A. A.
    Haverkos, B. H.
    Freud, A. G.
    Hastings, J.
    Nowacki, N. B.
    Barrionuevo, C.
    Vigil, C. E.
    Rochford, R.
    Natkunam, Y.
    Baiocchi, R. A.
    Porcu, P.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2015, 10 (04) : 456 - 467
  • [28] The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment
    A. A. Gru
    B. H. Haverkos
    A. G. Freud
    J. Hastings
    N. B. Nowacki
    C. Barrionuevo
    C. E. Vigil
    R. Rochford
    Y. Natkunam
    R. A. Baiocchi
    P. Porcu
    Current Hematologic Malignancy Reports, 2015, 10 : 456 - 467
  • [29] Epstein-Barr virus load correlating with clinical manifestation and treatment response in a patient with angioimmunoblastic T-cell lymphoma
    Battegay, M
    Berger, C
    Rochlitz, C
    Hurwitz, N
    Hirsch, HH
    De Geyter, C
    Haque, T
    Nadal, D
    ANTIVIRAL THERAPY, 2004, 9 (03) : 453 - 459
  • [30] Frequent expression of the Epstein-Barr virus encoded BZLF1 protein in angioimmunoblastic T-cell lymphoma
    Anagnostopoulos, Ioannis
    Joehrens, Korinna
    LEUKEMIA & LYMPHOMA, 2014, 55 (03) : 677 - 679